Dubeau, Alix https://orcid.org/0009-0009-2323-8760
El Balqui, Meryeme https://orcid.org/0009-0007-1665-725X
Talbot, Denis https://orcid.org/0000-0003-0431-3314
Rousseau, François https://orcid.org/0000-0002-4504-5507
Langlois, Sylvie https://orcid.org/0000-0001-9301-3625
Chen, Weihong
Audibert, François https://orcid.org/0000-0002-2697-3826
Bujold, Emmanuel https://orcid.org/0000-0002-6936-4369
Forest, Jean-Claude https://orcid.org/0000-0002-5910-5822
Dofara, Suélène Georgina https://orcid.org/0009-0008-0537-8965
Légaré, France https://orcid.org/0000-0002-2296-6696
Article History
Received: 30 June 2025
Accepted: 3 February 2026
First Online: 7 March 2026
Declarations
:
: The trial was registered at ClinicalTrials.gov (ID: NCT03831256). The trial began only after approval from the Ethics Review Committees of both the University of British Columbia (UBC) and the CHU de Québec – Université Laval. (UBC Research Ethics Board under #H18-02062 and Comité d’éthique du CHU de Québec #MP-20–2019–4332). The trial was registered on February 5 th , 2019.
: Not applicable.
: The authors declare no competing financial or non-financial interests related to this manuscript.